A Study of 1592U89 in HIV-Infected Patients

Effectiveness of ABT-378/Ritonavir Plus Lamivudine Plus Efavirenz Plus Tenofovir DF in HIV-Infected Patients

NCT00038220 ·Status: COMPLETED ·Phase: PHASE2

Effectiveness of the Early Addition of Abacavir to an Anti-HIV Drug Combination

NCT00001132 ·Status: COMPLETED ·Phase: PHASE2

A Single Dose Pharmacokinetic (PK) and Safety Study of GSK2838232 With and Without Ritonavir (RTV) Conducted in Healthy Subjects

NCT02289482 ·Status: TERMINATED ·Phase: PHASE1

A Safety, Pharmacokinetics, and Pharmacodynamics Study of ABX464 in HIV-1 Seronegative and Seropositive Adults

NCT02990325 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study of Ritonavir (ABT-538) When Used With Nelfinavir in HIV-Infected Patients

NCT00002201 ·Status: COMPLETED ·Phase: NA

Comparison of GW433908/Ritonavir to Nelfinavir When Used With Abacavir and Lamivudine in Patients That Have Not Taken Antiretroviral Drugs

NCT00009061 ·Status: UNKNOWN ·Phase: PHASE3

An Open-Label Study to Evaluate the Efficacy and Safety of Amprenavir (141W94) and Abacavir Combination Therapy in Protease Inhibitor Experienced Subjects With HIV-1 Infection Who Are Failing Their Current Antiretroviral Treatment Regimen

NCT00002205 ·Status: COMPLETED ·Phase: NA

Blood Levels of Abacavir After One Dose in HIV-Infected Children and Adolescents

NCT00011479 ·Status: COMPLETED ·Phase: PHASE1

Safety Study of Lopinavir/Ritonavir With Raltegravir in HIV-infected Patients

NCT00752037 ·Status: COMPLETED ·Phase: PHASE4

A Study of ABT-378/Ritonavir Combination in HIV-Infected Patients Who Have Taken Protease Inhibitors

NCT00004580 ·Status: COMPLETED ·Phase: PHASE1

Bioequivalence Study of Atazanavir 300 mg Capsule

NCT00393328 ·Status: COMPLETED ·Phase: PHASE1

A Study to Determine the Antiviral Activity of TMC310911 When Administered With Ritonavir in Treatment-Naive Human Immunodeficiency Virus - Type 1 (HIV-1) Infected Patients

NCT00838162 ·Status: COMPLETED ·Phase: PHASE2

Efficacy of Simplified Two Drug Kaletra Regimen vs. Kaletra Triple Drug Standard of Care Regimen in Treatment naïve HIV Infected Patients

NCT00234910 ·Status: COMPLETED ·Phase: PHASE3

A Repeat Dose Pharmacokinetic (PK) and Safety Study of GSK2838232 With and Without Ritonavir (RTV) Conducted in Healthy Subjects

NCT02289495 ·Status: TERMINATED ·Phase: PHASE1

Amprenavir/Ritonavir or Saquinavir/Ritonavir in HIV-Infected Subjects Following Failure With Kaletra as Their Second Protease Inhibitor

NCT00038519 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Blood Levels of Abacavir in HIV Infected Adolescents

NCT00087945 ·Status: COMPLETED ·Phase: NA

Once-Daily Drug Regimen for HIV-Infected Patients

NCT00001968 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate Antiviral Activity of Darunavir + Ritonavir in HIV-1 Infected Adolescents

NCT00915655 ·Status: COMPLETED ·Phase: PHASE2

TMC114-C202: A Study of Safety, Efficacy, and Tolerability of TMC114 and Low Dose Ritonavir in HIV-1 Infected Patients

NCT00071097 ·Status: COMPLETED ·Phase: PHASE2

Phase I Pharmacokinetic and Tolerance Study of Ribavirin in Human Immunodeficiency Virus (HIV) - Infected Patients

NCT00000733 ·Status: COMPLETED ·Phase: PHASE1

Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults

NCT00118898 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess the Safety, Tolerability and Pharmacokinetics of Lipovirtide in HIV-infected Patients

NCT04592315 ·Status: COMPLETED ·Phase: PHASE1

A Study of Saquinavir/Ritonavir in Liver-Impaired Patients With HIV Infection.

NCT00435929 ·Status: COMPLETED ·Phase: PHASE1

Viral Dynamics and Pharmacokinetics of Abacavir and Tenofovir

NCT00214890 ·Status: COMPLETED ·Phase: PHASE2

Safety and Acceptability Study of Non-occupational Prophylaxis (PEP) Following Potential Exposure to HIV

NCT01602822 ·Status: TERMINATED ·Phase: PHASE4